<DOC>
	<DOCNO>NCT01541228</DOCNO>
	<brief_summary>Aim study : To evaluate clinical effectiveness two different light dos treat actinic keratoses photodynamic therapy 20 % 5-aminolevulinic acid .</brief_summary>
	<brief_title>Photodynamic Treatment Actinic Keratoses With Different Light Doses</brief_title>
	<detailed_description>To determine compare clinical histological effectiveness different ( 70 J/cm2 ir 100 J/cm2 ) light dos treat actinic keratoses photodynamic therapy . To determine pain intensity photodynamic therapy visual analogue scale factor influence pain procedure .</detailed_description>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<criteria>1 . Male female subject old 50 year . 2 . Subject read Patient Information Sheet read sign Informed Consent form prior study related procedure . 3 . AK large diameter â‰¤3 cm ( measure long axis ) . 4 . 2 AK symmetrical distribution face scalp . 5 . Clinically histologically confirm AK grade I II . 6 . Subject must willing capable cooperate extent degree require protocol . 7 . Patient subject administrative legal judicial proceeding . 8 . Subject social health security require law health care institution . 1 . Patients 5 AK plan treatment area . 2 . A recurrent AK : AK previously treat study area . 3 . Very hyperkeratotic , grade 3 ( 03 scale ) AK lesion among target lesion . 4 . AK locate nose . 5 . Other skin lesion ( disease ) tumor study area . 6 . Subject know hereditary basal cell carcinoma syndrome ( GorlinGoltz , BasexDupreChristol et al. ) . 7 . Subject history cutaneous photosensitization porphyria Xeroderma pigmentosum , hypersensitivity porphyrin , photodermatosis . 8 . Subject receive photosensitize drug 30 day study start . 9 . Subjects receive immunomodulatory immunosuppressive therapy , include systemic topical steroid , imiquimod solaraze , interferon acitretin 6 month prior study treatment initiation . 10 . Subject participate another investigational drug device research study within 30 day enrolment . 11 . Subject receive study area laser resurfacing , chemical peel , topical application fluorouracil drug treatment AKs within 2 month study entry . 12 . Subject know hypersensitivity 5aminolevulinc acid , similar compound excipients cream . 13 . Subject know status organ transplantation .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>actinic keratosis</keyword>
	<keyword>photodynamic therapy</keyword>
	<keyword>5-aminolevulinic acid</keyword>
</DOC>